Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Twagirumukiza, Marc ^a,b   Kayumba, Pierre Claver ^c,d   Kips, Jan G ^a   Vrijens, Bernard ^e   Stichele, Robert Vander ^a   Vervaet, Chris ^c   Remon, Jean Paul ^c   Van Bortel, M Luc ^a  

^a GHENT UNIVERSITY   (Belgium)

^b University Teaching Hospital   (Rwanda)

^c GHENT UNIVERSITY   (Belgium)

^d Department of Pharmacy   (Rwanda)

^e UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

QUININE SULFATE; ANTIMALARIAL AGENT; QUININE;

ARTICLE; CLINICAL EVALUATION; CONSUMER ATTITUDE; CONTROLLED STUDY; DRUG FORMULATION; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALARIA; OUTPATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; PRESCRIPTION; SELF REPORT; TREATMENT DURATION; UNIVERSITY HOSPITAL; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG PACKAGING; EVALUATION; FEMALE; INFANT; INSTRUMENTATION; LENGTH OF STAY; MALE; NEWBORN; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; RWANDA; STATISTICS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTIMALARIALS; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG PACKAGING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALARIA; MALE; MEDICATION ADHERENCE; QUININE; RWANDA; TREATMENT OUTCOME;

EID: 77954548356     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-206     Document Type: Article

References (24)

1. Ongoing challenges in the management of malaria. G Kokwaro, Malar J 2009 8 Suppl 1 2 10.1186/1475-2875-8-S1-S2 19818169
2. Guidelines for the treatment of malaria. WHO, Geneva: World Health Organization Second 2010
3. Practical issues in medication compliance. JA Cramer, Transplant Proc 1999 31 7S 9S 10.1016/S0041-1345(99)00112-8 10372032
4. Measurement of patient compliance on drug therapy: an overview. E De Klerk, Advances in behavioral medicine assesment Harwood academic Publishers, Vingerhoets A, 2001
5. Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. E Depoortere JP Guthmann N Sipilanyambe E Nkandu F Fermon S Balkan D Legros, Trop Med Int Health 2004 9 62 67 10.1046/j.1365-3156.2003.01157.x 14728608
6. Adherence to antimalarial combination therapy with sulfadoxine- pyrimethamine and artesunate in rural Tanzania. SP Kachur RA Khatib E Kaizer SS Fox SM Abdulla PB Bloland, Am J Trop Med Hyg 2004 71 715 722 15642960
7. In search of the gold standard for compliance measurement. P Rudd, Arch Intern Med 1979 139 627 628 10.1001/archinte.139.6.627 443963
8. Determinants of poor adherence in hypertensive patients: development and validation of the "Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire". G Wetzels P Nelemans WB van N Broers J Schouten M Prins, Patient Educ Couns 2006 64 151 158 10.1016/j.pec.2005.12.010 16427764
9. Electronic monitoring and counseling to improve medication adherence. MI Rosen MO Rigsby JT Salahi CE Ryan JA Cramer, Behaviour Research and Therapy 2004 42 409 422 10.1016/S0005-7967(03)00149-9 14998735
10. Electronic monitoring of adherence as a tool to improve blood pressure control a randomized controlled trial. GE Wetzels PJ Nelemans JS Schouten CD Dirksen WT van der HE Stoffers R Janknegt PW de Leeuw MH Prins, Am J Hypertens 2007 20 119 125 10.1016/j.amjhyper.2006.07.018 17261454
11. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. PW Choo CS Rand TS Inui ML Lee E Cain M Cordeiro-Breault C Canning R Platt, Med Care 1999 37 846 857 10.1097/00005650-199909000-00002 10493464
12. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. E Diaz H Levine MC Sullivan MJ Sernyak KA Hawkins JA Cramer SW Woods, J Psychiatry Neurosci 2001 26 325 329 11590972
13. Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. PW Hugen N Langebeek DM Burger B Zomer LR van R Schuurman PP Koopmans YA Hekster, J Acquir Immune Defic Syndr 2002 30 324 334 12131570
14. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. JY Lee JW Kusek PG Greene S Bernhard K Norris D Smith B Wilkening JT Wright Jr, Am J Hypertens 1996 9 719 725 10.1016/0895-7061(96)00056-8 8862216
15. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. JM Mallion C Dutrey-Dupagne L Vaur N Genes M Renault F Elkik P Baguet S Boutelant, J Hypertens 1996 14 137 144 12013487
16. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. DJ Bell D Wootton M Mukaka J Montgomery N Kayange P Chimpeni DA Hughes ME Molyneux SA Ward PA Winstanley DG Lalloo, Malar J 2009 8 204 10.1186/1475-2875-8-204 19709418
17. Taste-masked quinine sulphate pellets: bio-availability in adults and steady-state plasma concentrations in children with uncomplicated Plasmodium falciparum malaria. PC Kayumba M Twagirumukiza N Huyghebaert JD Ntawukuliryayo L Van Bortel C Vervaet JP Remon, Ann Trop Paed 2008 28 103 109 10.1179/146532808X302116
18. Monitoring antimalarial drug rsistance: Report of WHO consultation. World Health Organization, Geneva: WHO 2001
19. Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal. A Souares R Lalou I Sene D Sow JY Le Hesran, Malar J 2009 8 118 10.1186/1475-2875-8-118 19497103
20. Appropriate treatment of malaria? Use of antimalarial drugs for children's fevers in district medical units, drug shops and homes in eastern Uganda. N Nshakira M Kristensen F Ssali SR Whyte, Trop Med Int Health 2002 7 309 316 10.1046/j.1365-3156.2002.00858.x 11952946
21. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. C Fogg F Bajunirwe P Piola S Biraro F Checchi J Kiguli P Namiiro J Musabe A Kyomugisha JP Guthmann, Am J Trop Med Hyg 2004 71 525 530 15569777
22. Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications. K Namkoong CK Farren PG O'Connor SS O'Malley, J Clin Psychiatry 1999 60 449 453 10453799
23. Measuring adherence among HIV-infected persons: Iis MEMS consummate technology? HS Jeffrey MS Lisa TT Elizabeth RI Jeannette, AIDS and Behavior 2001 5 21 30 10.1023/A:1009503320498 (Pubitemid 35364154)
24. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. M Byerly R Fisher K Whatley R Holland F Varghese T Carmody B Magouirk AJ Rush, Psychiatry Res 2005 133 129 133 10.1016/j.psychres.2004.11.002 15740989